About Sepax Technologies
Sepax Technologies is a company based in Newark (United States) founded in 2002.. Sepax Technologies has raised $109.24 million across 3 funding rounds from investors including Fosun, Gan & Lee Pharmaceutical and Sinopharm Capital. The company has 57 employees as of December 31, 2022. Sepax Technologies offers products and services including Proteomix HIC Butyl, Zenix-C SEC, Monomix TM MC SEC Resins, and Proteomix RP-1000. Sepax Technologies operates in a competitive market with competitors including ChromaTan, Upfront Chromatography, Natrix Separations, Reach Separations and PharmaFluidics, among others.
- Headquarter Newark, United States
- Employees 57 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sepax Technologies, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$109.24 M (USD)
in 3 rounds
-
Latest Funding Round
$78.36 M (USD), Series D
Nov 15, 2021
-
Investors
Fosun
& 7 more
-
Employee Count
57
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sepax Technologies
Sepax Technologies offers a comprehensive portfolio of products and services, including Proteomix HIC Butyl, Zenix-C SEC, Monomix TM MC SEC Resins, and Proteomix RP-1000. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables high-resolution hydrophobic interaction for biomolecules like mAbs.
Analyzes aggregates and fragments in antibody drug conjugates.
Provides stable SEC for broad pH ranges in protein purification.
Supports drug-to-antibody ratio analysis in ADCs.
Unlock access to complete
Funding Insights of Sepax Technologies
Sepax Technologies has successfully raised a total of $109.24M across 3 strategic funding rounds. The most recent funding activity was a Series D round of $78.36 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series D — $78.4M
- First Round First Round
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2021 | Amount | Series D - Sepax Technologies | Valuation |
investors |
|
| Mar, 2021 | Amount | Series C - Sepax Technologies | Valuation | China Life Insurance , Fosun |
|
| Jun, 2018 | Amount | Series A - Sepax Technologies | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sepax Technologies
Sepax Technologies has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Fosun, Gan & Lee Pharmaceutical and Sinopharm Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sepax Technologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Sepax Technologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sepax Technologies Comparisons
Competitors of Sepax Technologies
Sepax Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ChromaTan, Upfront Chromatography, Natrix Separations, Reach Separations and PharmaFluidics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Continuous countercurrent tangential chromatography separation technology is developed.
|
|
| domain | founded_year | HQ Location |
Chromatography technologies for protein separation and biomolecule recovery are provided.
|
|
| domain | founded_year | HQ Location |
Provider of proprietary filtration solutions for life science
|
|
| domain | founded_year | HQ Location |
Small molecule analysis and purification services are provided using chromatography.
|
|
| domain | founded_year | HQ Location |
Microchip liquid chromatography cartridges are supplied for nano-LC applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Sepax Technologies
When was Sepax Technologies founded?
Sepax Technologies was founded in 2002 and raised its 1st funding round 16 years after it was founded.
Where is Sepax Technologies located?
Sepax Technologies is headquartered in Newark, United States. It is registered at Newark, New Jersey, United States.
Is Sepax Technologies a funded company?
Sepax Technologies is a funded company, having raised a total of $109.24M across 3 funding rounds to date.
How many employees does Sepax Technologies have?
As of Dec 31, 2022, the latest employee count at Sepax Technologies is 57.
What does Sepax Technologies do?
Sepax Technologies was founded in 2002 and is based in Newark, United States. Operations focus on the biotechnology sector, where products such as particle synthesis, surface modifications, LC column packing, and bulk media are produced for modalities including size exclusion, ion exchange, and reversed phase chromatography. Services encompass analytical chromatography, preparative purification, custom resins, and surface coatings, supporting biomolecular separation processes across various applications.
Who are the top competitors of Sepax Technologies?
Sepax Technologies's top competitors include ChromaTan, Sepragen and Semba Biosciences.
What products or services does Sepax Technologies offer?
Sepax Technologies offers Proteomix HIC Butyl, Zenix-C SEC, Monomix TM MC SEC Resins, and Proteomix RP-1000.
Who are Sepax Technologies's investors?
Sepax Technologies has 8 investors. Key investors include Fosun, Gan & Lee Pharmaceutical, Sinopharm Capital, Sherpa Healthcare Partners, and Hillhouse Ventures.